Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice
- PMID: 15765150
- PMCID: PMC1052003
- DOI: 10.1172/JCI23625
Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice
Abstract
Essential tremor is the most common movement disorder and has an unknown etiology. Here we report that gamma-aminobutyric acidA (GABA(A)) receptor alpha1-/- mice exhibit postural and kinetic tremor and motor incoordination that is characteristic of essential tremor disease. We tested mice with essential-like tremor using current drug therapies that alleviate symptoms in essential tremor patients (primidone, propranolol, and gabapentin) and several candidates hypothesized to reduce tremor, including ethanol; the noncompetitive N-methyl-D-aspartate receptor antagonist MK-801; the adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA); the GABA(A) receptor modulators diazepam, allopregnanolone, and Ro15-4513; and the L-type Ca2+ channel antagonist nitrendipine. Primidone, propranolol, and gabapentin reduced the amplitude (power) of the pathologic tremor. Nonsedative doses of ethanol eliminated tremor in mice. Diazepam, allopregnanolone, Ro15-4513, and nitrendipine had no effect or enhanced tremor, whereas MK-801 and CCPA reduced tremor. To understand the etiology of tremor in these mice, we studied the electrophysiological properties of cerebellar Purkinje cells. Cerebellar Purkinje cells in GABA(A) receptor alpha1-/- mice exhibited a profound loss of all responses to synaptic or exogenous GABA, but no differences in abundance, gross morphology, or spontaneous synaptic activity were observed. This genetic animal model elucidates a mechanism of GABAergic dysfunction in the major motor pathway and potential targets for pharmacotherapy of essential tremor.
Figures



Comment in
-
Genetic mouse models of essential tremor: are they essential?J Clin Invest. 2005 Mar;115(3):584-6. doi: 10.1172/JCI24544. J Clin Invest. 2005. PMID: 15765140 Free PMC article.
Similar articles
-
Pharmacological characterization of harmaline-induced tremor activity in mice.Eur J Pharmacol. 2009 Aug 15;616(1-3):73-80. doi: 10.1016/j.ejphar.2009.05.031. Epub 2009 Jun 2. Eur J Pharmacol. 2009. PMID: 19497322
-
Genetic mouse models of essential tremor: are they essential?J Clin Invest. 2005 Mar;115(3):584-6. doi: 10.1172/JCI24544. J Clin Invest. 2005. PMID: 15765140 Free PMC article.
-
Lack of CaV3.1 channels causes severe motor coordination defects and an age-dependent cerebellar atrophy in a genetic model of essential tremor.Biochem Biophys Res Commun. 2011 Jun 24;410(1):19-23. doi: 10.1016/j.bbrc.2011.05.082. Epub 2011 May 20. Biochem Biophys Res Commun. 2011. PMID: 21621520
-
Essential tremor: differential diagnosis and current therapy.Am J Med. 2003 Aug 1;115(2):134-42. doi: 10.1016/s0002-9343(03)00259-6. Am J Med. 2003. PMID: 12893400 Review.
-
Brain circuits and neurochemical systems in essential tremor: insights into current and future pharmacotherapeutic approaches.Expert Rev Neurother. 2018 Feb;18(2):101-110. doi: 10.1080/14737175.2018.1413353. Epub 2017 Dec 15. Expert Rev Neurother. 2018. PMID: 29206482 Review.
Cited by
-
Homozygous SLC6A17 mutations cause autosomal-recessive intellectual disability with progressive tremor, speech impairment, and behavioral problems.Am J Hum Genet. 2015 Mar 5;96(3):386-96. doi: 10.1016/j.ajhg.2015.01.010. Epub 2015 Feb 19. Am J Hum Genet. 2015. PMID: 25704603 Free PMC article.
-
Propranolol Modulates Cerebellar Circuit Activity and Reduces Tremor.Cells. 2022 Dec 1;11(23):3889. doi: 10.3390/cells11233889. Cells. 2022. PMID: 36497147 Free PMC article.
-
Imaging the role of GABA in movement disorders.Curr Neurol Neurosci Rep. 2013 Oct;13(10):385. doi: 10.1007/s11910-013-0385-9. Curr Neurol Neurosci Rep. 2013. PMID: 23990356 Review.
-
Ethanol activation of protein kinase A regulates GABAA α1 receptor function and trafficking in cultured cerebral cortical neurons.J Pharmacol Exp Ther. 2013 May;345(2):317-25. doi: 10.1124/jpet.112.201954. Epub 2013 Feb 13. J Pharmacol Exp Ther. 2013. PMID: 23408117 Free PMC article.
-
Knowledge gaps and research recommendations for essential tremor.Parkinsonism Relat Disord. 2016 Dec;33:27-35. doi: 10.1016/j.parkreldis.2016.10.002. Epub 2016 Oct 4. Parkinsonism Relat Disord. 2016. PMID: 27769649 Free PMC article. Review.
References
-
- Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov. Disord. 1998;13:5–10. - PubMed
-
- Chen JJ, Swope DM. Essential tremor: diagnosis and treatment. Pharmacotherapy. 2003;23:1105–1122. - PubMed
-
- Pahwa R, Lyons KE. Essential tremor: Differential diagnosis and current therapy. Am. J. Med. 2003;115:134–142. - PubMed
-
- Hubble JP, Busenbark KL, Pahwa R, Lyons K, Koller WC. Clinical expression of essential tremor: effects of gender and age. Mov. Disord. 1997;12:969–972. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous